Literature DB >> 25959644

Not only for the risk of bone fracture.

Masafumi Fukagawa1.   

Abstract

Entities:  

Keywords:  Cardiovasucular event; Chronic kidney disease; FRAX; Fracture; Survival

Mesh：

Year:  2015        PMID： 25959644     DOI： 10.1007/s00774-015-0661-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN： 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  30 in total

1.  Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.

Authors:  Masafumi Fukagawa; Keitaro Yokoyama; Fumihiko Koiwa; Masatomo Taniguchi; Tetsuo Shoji; Junichiro James Kazama; Hirotaka Komaba; Ryoichi Ando; Takatoshi Kakuta; Hideki Fujii; Msasaaki Nakayama; Yugo Shibagaki; Seiji Fukumoto; Naohiko Fujii; Motoshi Hattori; Akira Ashida; Kunitoshi Iseki; Takashi Shigematsu; Yusuke Tsukamoto; Yoshiharu Tsubakihara; Tadashi Tomo; Hideki Hirakata; Tadao Akizawa
Journal:  Ther Apher Dial       Date:  2013-06       Impact factor: 1.762

2.  The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease.

Authors:  S A Jamal; S L West; T L Nickolas
Journal:  Osteoporos Int       Date:  2013-10-11       Impact factor: 4.507

3.  FRAX predicts fracture risk in kidney transplant recipients.

Authors:  Kyla L Naylor; William D Leslie; Anthony B Hodsman; David N Rush; Amit X Garg
Journal:  Transplantation       Date:  2014-05-15       Impact factor: 4.939

4.  Increased risk of hip fracture among Japanese hemodialysis patients.

Authors:  Minako Wakasugi; Junichiro James Kazama; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Ichiei Narita
Journal:  J Bone Miner Metab       Date:  2013-01-06       Impact factor: 2.626

5.  The FRAX ® as a predictor of mortality in Japanese incident hemodialysis patients: an observational, follow-up study.

Authors:  Toshihide Hayashi; Nobuhiko Joki; Yuri Tanaka; Masaki Iwasaki; Shun Kubo; Takasuke Asakawa; Ai Matsukane; Yasunori Takahashi; Yoshihiko Imamura; Koichi Hirahata; Hiroki Hase
Journal:  J Bone Miner Metab       Date:  2015-02-18       Impact factor: 2.626

6.  Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.

Authors:  T Nii-Kono; Y Iwasaki; M Uchida; A Fujieda; A Hosokawa; M Motojima; H Yamato; K Kurokawa; M Fukagawa
Journal:  Kidney Int       Date:  2007-01-31       Impact factor: 10.612

7.  Chronic kidney disease and bone metabolism.

Authors:  Junichiro James Kazama; Koji Matsuo; Yoshiko Iwasaki; Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2015-02-05       Impact factor: 2.626

8.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

9.  FGF23 regulates renal sodium handling and blood pressure.

Authors:  Olena Andrukhova; Svetlana Slavic; Alina Smorodchenko; Ute Zeitz; Victoria Shalhoub; Beate Lanske; Elena E Pohl; Reinhold G Erben
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

10.  Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX).

Authors:  S Fujiwara; T Nakamura; H Orimo; T Hosoi; I Gorai; A Oden; H Johansson; J A Kanis
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.